Patient satisfaction with calcipotriol/betamethasone dipropionate cutaneous foam for the treatment of plaque psoriasis: The LION real‐life multicenter prospective observational cohort study

Topical treatment is the mainstay for mild or moderate psoriasis, but patients are generally little satisfied. Calcipotriol/betamethasone dipropionate (Cal/BD) cutaneous foam has shown to improve signs and symptoms in plaque psoriasis patients. This study assessed patient's satisfaction with Ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Campanati, Anna, Atzori, Laura, Potenza, Concetta, Damiani, Giovanni, Bianchi, Luca, Corazza, Monica, Tiberio, Rossana, Prignano, Francesca, Argenziano, Giuseppe, Fargnoli, Maria Concetta, Stingeni, Luca, Mazzotta, Annamaria, De Pità, Ornella, Mazzatenta, Carlo, Feliciani, Claudio, Donini, Massimo, Offidani, Annamaria, Peris, Ketty
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285427/
https://www.ncbi.nlm.nih.gov/pubmed/34333823
http://dx.doi.org/10.1111/dth.15077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285427/
https://www.ncbi.nlm.nih.gov/pubmed/34333823
http://dx.doi.org/10.1111/dth.15077

Ejemplares similares